Brought to you by 
Elixir files for 5mm-share IPO; withdrawn
15 May 2008
Executive Summary
Elixir Pharmaceuticals (therapeutics for metabolic disorders) hopes to sell 5mm shares priced between $14-16 each in its initial public offering. The company originally filed in September.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Withdrawn
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com